1,728 results on '"Canonica, Giorgio Walter"'
Search Results
2. Exploring Definitions and Predictors of Response to Biologics for Severe Asthma
3. International Variation in Severe Exacerbation Rates in Patients With Severe Asthma
4. Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
5. Efficacy of 300 IR 5-grass sublingual immunotherapy tablet for allergic rhino-conjunctivitis
6. Local Allergic Rhinitis
7. Asthma patients' and physicians’ perspectives on the burden and management of asthma: Post-hoc analysis of APPaRENT 1 and 2 to assess predictors of treatment adherence
8. IR (index of reactivity)-house dust mite sublingual immunotherapy liquid formulation for allergic rhinoconjunctivitis: Systematic review and meta-analysis of randomized and nonrandomized studies
9. Respiratory allergic diseases and allergen immunotherapy: A French patient survey before and during the COVID-19 pandemic
10. Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study
11. A Charter to Fundamentally Change the Role of Oral Corticosteroids in the Management of Asthma
12. Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials
13. Clinical benefits with 300 IR HDM SLIT tablet in Europeans with house dust mite allergic rhinitis: Post hoc analysis of a large phase 3 trial
14. Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry
15. Sleep quality burden in chronic rhinosinusitis with nasal polyps and its modulation by dupilumab
16. Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi Consensus
17. Advancing precision medicine in asthma: Evolution of treatment outcomes
18. Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry
19. Update meta-analysis on the efficacy and safety issues of fexofenadine
20. A Renewed Charter: Key Principles to Improve Patient Care in Severe Asthma
21. The Prescribing Practice for COPD: Relationship to Circadian Rhythm, Disease Severity, and Clinical Phenotype in the STORICO Observational Study
22. Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy
23. COPD and biologic treatment: state of the art
24. Questionnaire Validation: A User Guide for Allergy Research
25. Systemic corticosteroids in asthma: A call to action from World Allergy Organization and Respiratory Effectiveness Group
26. Nasal cytology as a reliable non-invasive procedure to phenotype patients with type 2 chronic rhinosinusitis with nasal polyps
27. Is asthma control more than just an absence of symptoms? An expert consensus statement
28. REALITI-A Study: Real-World Oral Corticosteroid-Sparing Effect of Mepolizumab in Severe Asthma
29. Patients' and physicians’ perspectives on the burden and management of asthma: Results from the APPaRENT 2 study
30. WAO-ARIA consensus on chronic cough – Part III: Management strategies in primary and cough-specialty care. Updates inCOVID-19
31. Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life
32. ChAracterization of ItaliaN severe uncontrolled Asthmatic patieNts Key features when receiving Benralizumab in a real-life setting: the observational rEtrospective ANANKE study
33. Current treatment strategies for seasonal allergic rhinitis: where are we heading?
34. Rhinitis and Asthma Patient Perspective (RAPP): Clinical Utility and Predictive Value
35. Why fexofenadine is considered as a truly non-sedating antihistamine with no brain penetration: a systematic review.
36. SANI Clinical Remission definition: a useful tool in Severe Asthma management.
37. WAO-ARIA consensus on chronic cough - Part II: Phenotypes and mechanisms of abnormal cough presentation — Updates inCOVID-19
38. WAO-ARIA consensus on chronic cough – Part 1: Role of TRP channels in neurogenic inflammation of cough neuronal pathways
39. Exploring the Potential Role of Metabolomics in COPD: A Concise Review
40. Meta‐analysis in allergy—Statistical recommendations
41. Unlocking the Long-Term Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A Three-Year Real-Life Study
42. Reply to “Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry”
43. Defining a Severe Asthma Super-Responder: Findings from a Delphi Process
44. Severe asthma: One disease and multiple definitions
45. Airways Type-2 Related Disorders: Multiorgan, Systemic or Syndemic Disease?
46. The challenges of chronic urticaria part 2: Pharmacological treatment, chronic inducible urticaria, urticaria in special situations
47. The challenges of chronic urticaria part 1: Epidemiology, immunopathogenesis, comorbidities, quality of life, and management
48. One Hundred Ten Years of Allergen Immunotherapy: A Broad Look Into the Future
49. Successful SARS-CoV-2 vaccine allergy risk-management: The experience of a large Italian University Hospital
50. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.